We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+10.55%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$3.14B
AUM Growth
+$728M
Cap. Flow
+$534M
Cap. Flow %
17.01%
Top 10 Hldgs %
37.86%
Holding
6,828
New
511
Increased
3,030
Reduced
2,253
Closed
625

Sector Composition

Rank Sector Weight
1 Technology 21.21%
2 Consumer Discretionary 7.37%
3 Financials 6.36%
4 Healthcare 5.92%
5 Industrials 5.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MDH
6776
DELISTED
MDH Acquisition Corp.
MDH
-737
Closed -$7K
RBCN
6777
DELISTED
Rubicon Technology, Inc.
RBCN
-5,863
Closed -$10K
OTIC
6778
DELISTED
Otonomy, Inc.
OTIC
-90
Closed
CLVS
6779
DELISTED
Clovis Oncology, Inc.
CLVS
-660
Closed
GROM
6780
DELISTED
Grom Social Enterprises Inc. Common Stock
GROM
-156
Closed -$5K
TUEM
6781
DELISTED
Tuesday Morning Corp
TUEM
-5,864
Closed -$4K
FSRDW
6782
DELISTED
Fast Radius, Inc. Warrants
FSRDW
-34
Closed
SMTS
6783
DELISTED
Sierra Metals Inc. Common Stock
SMTS
-632
Closed
FNHC
6784
DELISTED
FedNat Holding Company Common Stock
FNHC
-16,290
Closed
QTNT
6785
DELISTED
Quotient Limited Ordinary Shares
QTNT
$0 ﹤0.01%
100
PMVC.WS
6786
DELISTED
PMV Consumer Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
PMVC.WS
-140
Closed
GBL
6787
DELISTED
GAMCO Investors, Inc.
GBL
-56
Closed -$1K
EMBK
6788
DELISTED
Embark Technology, Inc. Common Stock
EMBK
-88
Closed
XELA
6789
DELISTED
Exela Technologies, Inc. Common Stock
XELA
0
PBLA
6790
DELISTED
Panbela Therapeutics, Inc. Common Stock
PBLA
-1
Closed -$1K
POTX
6791
DELISTED
Global X Cannabis ETF
POTX
-161
Closed -$2K
CHGX
6792
DELISTED
AXS Change Finance ESG ETF
CHGX
-17,097
Closed -$464K
NBRV
6793
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
-8
Closed
AVEO
6794
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
-8,703
Closed -$130K
ONCS
6795
DELISTED
OncoSec Medical Incorporated
ONCS
-1,883
Closed -$3K
MFGP
6796
DELISTED
Micro Focus International plc. American Depositary Shares, each representing One Ordinary Share
MFGP
-2,026
Closed -$13K
USLB
6797
DELISTED
Invesco Russell 1000 Low Beta Equal Weight ETF
USLB
$0 ﹤0.01%
9
DGL
6798
DELISTED
Invesco DB Gold Fund
DGL
-7
Closed
CEI
6799
DELISTED
Camber Energy, Inc
CEI
$0 ﹤0.01%
35
+34
+3,400% +$59
COWN
6800
DELISTED
Cowen Inc. Class A Common Stock
COWN
-2,296
Closed -$89K

Similar funds

Tower Research Capital (TRC)'s Q1 2023 Portfolio in Review

As of Q1 2023, Tower Research Capital (TRC) held 6,828 positions worth $3.14B, up 30% from $2.41B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Tower Research Capital (TRC) deployed $534M of net new capital in Q1 2023, opening 511 new positions and adding to 3,030 existing holdings. Its largest new stake was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $52.8M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2023 buy was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q1 2023, an estimated $204M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2023 reduction was iShares Russell 2000 ETF, cutting an estimated $52.8M.
  • Tower Research Capital (TRC) fully exited Myovant Sciences Ltd. in Q1 2023, selling an estimated $7.26M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 38% of its $3.14B portfolio in Q1 2023.
  • Tower Research Capital (TRC) opened 511 new positions and closed 625 in Q1 2023.
  • Tower Research Capital (TRC)'s portfolio value rose 30% quarter-over-quarter to $3.14B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2023, filed 9 May 2023.